Jesse Gelsinger (1981-1999) was the first person publicly known to have died in a gene therapy clinical trial. He had ornithine transcarbamylase deficiency, a genetic liver condition. In a trial at the University of Pennsylvania, he received an injection intended to correct his genetic issue but died from a severe immune response. His death raised serious ethical concerns and led to an investigation that found multiple regulatory violations by trial organizers. The incident halted gene therapy trials in the U.S. for a period, significantly impacting research in this field.
Zodiac Sign (Western)
Sunsign, Tropical Zodiac
Zodiac Sign (Vedic)
Moonsign, Sidereal Zodiac
Age (Today)
Your next birthday is 168 days away.
Death Anniversary
Next death anniversary is 105 days away.
Death Date
Place of Birth
Time Zone -
Chinese Zodiac Sign
Birth Number
Life Path Number
Name Number (Chaldean)
Name Number (Pythagorean)
Meaning of the name - Jesse
God will give
Read Full Jesse Name AnalysisJune 18, 1981 Facts
Generation Group
Jesse Gelsinger belongs to the Millennials group.
Cause of Death: multiple organ dysfunction syndrome
Astrology Analysis
Ephemeris for June 18, 1981
Note: Moon position is location and time sensitive.| Planet | Position (Tropical, Western) | Transits on June 18, 2024 | Secondary Progressions for June 18, 2024 |
|---|---|---|---|
| Sun | 27 Gemini 21 | 27 Gemini 56 | 8 Leo 23 |
| Moon | 9 Capricorn 36 | 17 Scorpio 34 | 15 Leo 18 |
| Mercury | 2 Cancer 25 | 2 Cancer 53 | 27 Cancer 52 |
| Venus | 16 Cancer 26 | 1 Cancer 47 | 8 Virgo 36 |
| Mars | 9 Gemini 33 | 7 Taurus 2 | 8 Cancer 57 |
| Jupiter | 1 Libra 0 | 5 Gemini 29 | 5 Libra 56 |
| Saturn | 3 Libra 33 | 19 Pisces 14 | 5 Libra 54 |
| Uranus | 26 Scorpio 58 | 25 Taurus 9 | 26 Scorpio 7 |
| Neptune | 23 Sagittarius 23 | 29 Pisces 52 | 22 Sagittarius 23 |
| Pluto | 21 Libra 35 | 1 Aquarius 37 | 21 Libra 47 |
| Rahu | 3 Leo 34 | 11 Aries 53 | 1 Leo 18 |
| Ketu | 3 Aquarius 34 | 11 Libra 53 | 1 Aquarius 18 |
Chandra Kundali (Equal House, North Indian Diamond Chart)
